HighPoint Advisor Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

HighPoint Advisor Group’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$37K	Hold	75	–	–	﹤0.01%	546
2021 Q2	$38K	Hold	75	–	–	﹤0.01%	535
2021 Q1	$41K	Sell	75 -30	-29%	-$15.5K	﹤0.01%	490
2020 Q4	$71K	Hold	105	–	–	0.01%	465
2020 Q3	$28K	Hold	105	–	–	0.01%	384
2020 Q2	$19K	Sell	105 -18	-15%	-$2.99K	﹤0.01%	353
2020 Q1	$19K	Sell	123 -23	-16%	-$4.16K	﹤0.01%	343
2019 Q4	$29K	Hold	146	–	–	0.01%	366
2019 Q3	$15K	Sell	146 -5	-3%	-$666	﹤0.01%	487
2019 Q2	$18K	Buy	+151	New	+$23.9K	﹤0.01%	485
2019 Q1	–	Sell	-178	Closed	-$33K	–	356
2018 Q4	$33K	Buy	+178	New	+$27.3K	0.01%	318

Other funds holding AMPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

HighPoint Advisor Group's AMPE Position: Q3 2021 in Review

HighPoint Advisor Group held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q3 2021 at 75 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

HighPoint Advisor Group first reported a position in AMPE in Q4 2018 and has held it in 11 quarters since. The position peaked at $71K in Q4 2020. 121 funds tracked by Wall St. Rank hold AMPE as of Q3 2021.

HighPoint Advisor Group held 75 shares of Ampio Pharmaceuticals Inc. worth $37K as of Q3 2021.
HighPoint Advisor Group left its Ampio Pharmaceuticals Inc. share count unchanged in Q3 2021.
Ampio Pharmaceuticals Inc. made up ﹤0.01% of HighPoint Advisor Group's portfolio in Q3 2021, its #546 holding.
HighPoint Advisor Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and has held it in 11 quarters since.
HighPoint Advisor Group's Ampio Pharmaceuticals Inc. position peaked at $71K in Q4 2020.
121 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2021.

Based on HighPoint Advisor Group's 13F filing for Q3 2021, filed 15 Nov 2021.